Literature DB >> 8454517

Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990)

A R Klag1, U Giger, F S Shofer.   

Abstract

Forty-two cases of Coombs' positive or agglutinating immune-mediated hemolytic anemia (IMHA) in dogs were reviewed. Dogs ranged in age from 1 to 13 years, with a mean age of 6.4 +/- 3.4 years. The majority of dogs (74%) tested positive for IgG antibodies without complement. Spherocytosis was seen in 67% of the dogs, but hemoglobinemia and hemoglobinuria were found in only 10%. Marked bilirubinuria was found in all the dogs. A significant seasonal incidence was observed, with 40% of all cases diagnosed during the months of May and June. Severe anemia, with PCV < or = 20% was observed in 37 dogs (88%). Sixteen dogs (38%) had moderate to severe reticulocytosis and 12 dogs (29%) had mild reticulocytosis. Thus, the absence of reticulocytosis should not be used to rule out a diagnosis of IMHA. Concomitant mild to severe thrombocytopenia was observed in 28 dogs (67%). A mortality of 29% was observed during hospitalization. Risk of death was significantly increased in dogs without marked reticulocytosis, those with lower PCV, and dogs with serum bilirubin concentrations > or = 10 mg/dl. In severe cases of IMHA, rapid and aggressive supportive therapy is required.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454517

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  18 in total

1.  Treatment of presumptive idiopathic immune-mediated anemia in a Holstein heifer, using blood transfusions and corticotherapy.

Authors:  Michaël Lallemand; Gilles Fecteau; Michel Desnoyer; David Francoz; Marie-Lou Gaucher
Journal:  Can Vet J       Date:  2006-07       Impact factor: 1.008

2.  Clinical pathology interpretation.

Authors:  B Horney
Journal:  Can Vet J       Date:  1998-03       Impact factor: 1.008

Review 3.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

4.  Diagnostic utility of thoracic radiographs and abdominal ultrasound in canine immune-mediated hemolytic anemia.

Authors:  Michael Andres; Erik Hostnik; Eric Green; Catherine Langston; Valerie J Parker; Chen Gilor; Adam J Rudinsky
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

5.  Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.

Authors:  Christine J Piek; Willem Evert van Spil; Greet Junius; Aldo Dekker
Journal:  BMC Vet Res       Date:  2011-04-13       Impact factor: 2.741

Review 6.  Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.

Authors:  J W Swann; B J Skelly
Journal:  J Vet Intern Med       Date:  2015-01-13       Impact factor: 3.333

7.  A case of non-regenerative immune-mediated anemia treated by combination therapy of human immune globulin and mycophenolate mofetil in a dog.

Authors:  M Yuki
Journal:  Open Vet J       Date:  2011-12-03

8.  Analysis of DLA-DQB1 and polymorphisms in CTLA4 in Cocker spaniels affected with immune-mediated haemolytic anaemia.

Authors:  Anna J Threlfall; Alisdair M Boag; Francesca Soutter; Barbara Glanemann; Harriet M Syme; Brian Catchpole
Journal:  Canine Genet Epidemiol       Date:  2015-06-09

9.  The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.

Authors:  Geert Paes; Dominique Paepe; Evelyne Meyer; Annemarie T Kristensen; Luc Duchateau; Miguel Campos; Sylvie Daminet
Journal:  Acta Vet Scand       Date:  2013-10-25       Impact factor: 1.695

10.  Comparison of 4 direct Coombs' test methods with polyclonal antiglobulins in anemic and nonanemic dogs for in-clinic or laboratory use.

Authors:  L L Caviezel; K Raj; U Giger
Journal:  J Vet Intern Med       Date:  2014-01-16       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.